Package Label-principal Display Panel (10 mg (500 Tablets Bottle))
Citalopram Tablet, Film Coated
Product Images NDC 82009-108
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram (NDC 82009-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (20 mg (500 Tablets Bottle))
Package Label-principal Display Panel (40 mg (500 Tablets Bottle))
Each tablet contains 40 mg of citalopram base as Gitalopram hydrobromide USP. This medication should be kept out of the reach of children. For full prescribing information, refer to the package insert. The tablets should be dispensed in a tight container as specified in the USP. They should be stored between 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). The medication was issued in March 2023 and consists of 500 tablets with NDC 82009-108-05. Citalopram Tablets, USP, should only be dispensed with a prescription (Rx only). A medication guide will be provided separately. Manufactured by Aurobindo Pharma Limited in Hyderabad, India, for Quallent Pharmaceuticals Health LLC in Grand Cayman, Cayman Islands. Additional coding information including GTIN, Serial Number, Expiry Date, and LOT will be printed during packing.*
Chemical Structure (Citalopram Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
